Y-90-Basixilimab
90Y-Basiliximab is a chimeric, mouse-human monoclonal antibody directed against the [...]
Lu-177-Rituximab
177Lu-Rituximab is the Lutetium-177 labeled analogue of 131I-Tositumomab (131I-Bexxar) for [...]
Y-90-Epratuzumab Tetratexan
90Y-Epratuzumab tetraxetan entered the clinical phase as early as 1996. [...]
Y-90-Daclizumab (HAT)
90Y-labeled humanized anti-Tac (90Y-HAT, 90Y-Daclizumab) is a radiolabeled monoclonal antibody [...]
I-131-Apamistamab (Iomab-B™)
131I-Apamistamab (131I-BC8, Iomab-B™) is an anti-CD45 radioimmunotherapy for the [...]
Lu-177-Lilotomab Satetraxetan (Betalutin)
Betalutin™ is the brand name of an anti-CD37 antibody labeled [...]
Bi-213-Lintuzumab (Bi-213 Bismab-A™)
213Bi-Lintuzumab (213Bi-Bismab-A™, 213Bi-CHX-A’’-DTPA-huM195) is an anti-CD33 humanized antibody huM195 labeled [...]
I-131-Tositumomab (Bexxar®)
131I-Tositumomab is a radiolabeled anti-CD20 antibody launched in 2003 under [...]
Th-227-Epratuzumab (Th-227-BAY1862864)
227Th-Epratuzumab (227Th-BAY1862864 is a CD-22 thorium conjugate targeting relapsed or [...]